GB0314725D0 - New antitumoral compounds - Google Patents

New antitumoral compounds

Info

Publication number: GB0314725D0
Authority: GB; United Kingdom
Prior art keywords: antitumoral compounds; new antitumoral; new; compounds; antitumoral
Prior art date: 2003-06-24
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

GB0314725A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Pharmamar SA

Original Assignee

Pharmamar SA

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-06-24

Filing date

2003-06-24

Publication date

2003-07-30

2003-06-24 Application filed by Pharmamar SA filed Critical Pharmamar SA

2003-06-24 Priority to GB0314725A priority Critical patent/GB0314725D0/en

2003-07-30 Publication of GB0314725D0 publication Critical patent/GB0314725D0/en

2003-10-20 Priority to CNA2007101122538A priority patent/CN101077885A/en

2003-10-20 Priority to PL377056A priority patent/PL209129B1/en

2003-10-20 Priority to ES03779140T priority patent/ES2357644T3/en

2003-10-20 Priority to DE60335292T priority patent/DE60335292D1/en

2003-10-20 Priority to PCT/US2003/033207 priority patent/WO2004035613A2/en

2003-10-20 Priority to CN200380101647A priority patent/CN100591691C/en

2003-10-20 Priority to DK03779140.7T priority patent/DK1572726T3/en

2003-10-20 Priority to KR1020057006480A priority patent/KR101149095B1/en

2003-10-20 Priority to US10/531,533 priority patent/US7507708B2/en

2003-10-20 Priority to HK06102999.1A priority patent/HK1082261B/en

2003-10-20 Priority to CA2501089A priority patent/CA2501089C/en

2003-10-20 Priority to KR1020117020121A priority patent/KR20110114690A/en

2003-10-20 Priority to SI200331948T priority patent/SI1572726T1/en

2003-10-20 Priority to AT03779140T priority patent/ATE490975T1/en

2003-10-20 Priority to AU2003285911A priority patent/AU2003285911B2/en

2003-10-20 Priority to PT03779140T priority patent/PT1572726E/en

2003-10-20 Priority to NZ539093A priority patent/NZ539093A/en

2003-10-20 Priority to MXPA05004133A priority patent/MXPA05004133A/en

2003-10-20 Priority to EP03779140A priority patent/EP1572726B1/en

2003-10-20 Priority to BR0315489-0A priority patent/BR0315489A/en

2003-10-20 Priority to JP2005501483A priority patent/JP4430009B2/en

2005-03-29 Priority to IL167724A priority patent/IL167724A/en

2005-04-11 Priority to ZA200502926A priority patent/ZA200502926B/en

2005-05-13 Priority to NO20052379A priority patent/NO333448B1/en

2008-01-25 Priority to US12/019,705 priority patent/US7683028B2/en

2011-03-08 Priority to CY20111100265T priority patent/CY1111319T1/en

Status Ceased legal-status Critical Current

Priority Applications (27)

Application Number	Priority Date	Filing Date	Title
GB0314725A GB0314725D0 (en)	2003-06-24	2003-06-24	New antitumoral compounds
JP2005501483A JP4430009B2 (en)	2002-10-18	2003-10-20	Novel antitumor compounds
KR1020117020121A KR20110114690A (en)	2002-10-18	2003-10-20	4-Methylhexano kahalad F compound
AT03779140T ATE490975T1 (en)	2002-10-18	2003-10-20	4-METHYLHEXANOIC KAHALALIDE F COMPOUND
ES03779140T ES2357644T3 (en)	2002-10-18	2003-10-20	KAHALALIDO F. 4-METHYLHEXANOIC COMPOUND
DE60335292T DE60335292D1 (en)	2002-10-18	2003-10-20	4-METHYLHEXANOIC KAHALALIDE F COMPOUND
PCT/US2003/033207 WO2004035613A2 (en)	2002-10-18	2003-10-20	4-methylhexanoic kahalaide f compound
CN200380101647A CN100591691C (en)	2002-10-18	2003-10-20	Novel Antitumor Compounds
DK03779140.7T DK1572726T3 (en)	2002-10-18	2003-10-20	4-methylhexanoic acid kahalalide F compound
KR1020057006480A KR101149095B1 (en)	2002-10-18	2003-10-20	4-Methylhexanoic kahalalide F compound
US10/531,533 US7507708B2 (en)	2003-02-26	2003-10-20	Antitumoral compounds
HK06102999.1A HK1082261B (en)	2002-10-18	2003-10-20	4-methylhexanoic kahalalide f compound
CA2501089A CA2501089C (en)	2002-10-18	2003-10-20	4-methylhexanoic kahalaide f compound
CNA2007101122538A CN101077885A (en)	2002-10-18	2003-10-20	New antitumoral compounds
SI200331948T SI1572726T1 (en)	2002-10-18	2003-10-20	4-methylhexanoic kahalalide f compound
PL377056A PL209129B1 (en)	2002-10-18	2003-10-20	New antitumoral compounds
AU2003285911A AU2003285911B2 (en)	2002-10-18	2003-10-20	4-methylhexanoic kahalaide F compound
PT03779140T PT1572726E (en)	2002-10-18	2003-10-20	4-methylhexanoic kahalalide f compound
NZ539093A NZ539093A (en)	2002-10-18	2003-10-20	4-methylhexanoic kahalaide F compound
MXPA05004133A MXPA05004133A (en)	2002-10-18	2003-10-20	4-methylhexanoic kahalaide f compound.
EP03779140A EP1572726B1 (en)	2002-10-18	2003-10-20	4-methylhexanoic kahalalide f compound
BR0315489-0A BR0315489A (en)	2002-10-18	2003-10-20	Antitumor Composition
IL167724A IL167724A (en)	2002-10-18	2005-03-29	Kahalalide derivatives and pharmaceutical compositions containing the same
ZA200502926A ZA200502926B (en)	2002-10-18	2005-04-11	4-Methylhexanoic kahalaide F compound.
NO20052379A NO333448B1 (en)	2002-10-18	2005-05-13	New 4-methylhexanoic acid kahalalide F compounds, methods for their preparation, their use for the preparation of a drug preferably for the treatment of cancer, pharmaceutical compositions comprising the compounds, and a kit containing a pharmaceutical composition comprising the compounds.
US12/019,705 US7683028B2 (en)	2003-02-26	2008-01-25	Kahalalide compositions
CY20111100265T CY1111319T1 (en)	2003-02-26	2011-03-08	4-Methyl-hexanoic acid compound F

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB0314725A GB0314725D0 (en)	2003-06-24	2003-06-24	New antitumoral compounds

Publications (1)

Publication Number	Publication Date
GB0314725D0 true GB0314725D0 (en)	2003-07-30

Family

ID=27637249

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GB0314725A Ceased GB0314725D0 (en)	2002-10-18	2003-06-24	New antitumoral compounds

Country Status (1)

Country	Link
GB (1)	GB0314725D0 (en)

2003
- 2003-06-24 GB GB0314725A patent/GB0314725D0/en not_active Ceased

Publication	Publication Date	Title
GB0322016D0 (en)	2003-10-22	New compounds
GB0309781D0 (en)	2003-06-04	Compounds
EP1592425A4 (en)	2007-01-24	New arylpiperazinyl compounds
GB0305559D0 (en)	2003-04-16	Compounds
GB0304665D0 (en)	2003-04-02	Compounds
GB0324201D0 (en)	2003-11-19	Improved antitumoral combinations
EP1689403A4 (en)	2007-09-05	Heteroaryl-hydrazone compounds
GB0305553D0 (en)	2003-04-16	Compounds
GB0306329D0 (en)	2003-04-23	Compounds
GB0303086D0 (en)	2003-03-19	New compounds
EP1682514A4 (en)	2008-07-16	11- o-methylgeldanamycin compounds
GB0302512D0 (en)	2003-03-05	Compounds
GB0304494D0 (en)	2003-04-02	Compounds
HUP0302440D0 (en)	2003-09-29	New compounds
GB0314725D0 (en)	2003-07-30	New antitumoral compounds
GB0317128D0 (en)	2003-08-27	Use of antitumoral compounds
GB0314724D0 (en)	2003-07-30	Antitumoral compounds
GB0318336D0 (en)	2003-09-10	Antitumoral compounds
GB0326067D0 (en)	2003-12-10	Antitumoral compounds
GB0327279D0 (en)	2003-12-24	Antitumoral compounds
GB0314304D0 (en)	2003-07-23	Antitumoral compounds
GB0307657D0 (en)	2003-05-07	Antitumoral compounds
GB0215630D0 (en)	2002-08-14	New antitumoral compounds
GB0313609D0 (en)	2003-07-16	Antitumoral compound
GB0313607D0 (en)	2003-07-16	Antitumoral compound

Legal Events

Date	Code	Title	Description
2004-09-22	AT	Applications terminated before publication under section 16(1)